secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-10-01T23:59:59+00:00
Accession:  0001640334-25-001766
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences closes $2M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$2M from 441,210 shares at $4.40/share and 13,335 pre-funded warrants at $4.399/warrant (ex. price $0.001).
- Underwriter R.F. Lafferty has 45-day option to purchase up to additional 68,181 shares/warrants for overallotments.
- Net proceeds will advance preclinical/clinical development, manufacturing, and working capital needs.
- Directors, officers subject to 30-day lock-up; company granted R.F. Lafferty right of first refusal through Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001766/0001640334-25-001766-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001766/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001766

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer